99% Pure | Multi Dose | Finished in the USACartalax Peptide is a short-chain peptide studied for its regenerative potential in connective tissue, particularly cartilage. Originating from Russian peptide research programs, Cartalax has shown promise in models exploring cartilage health, joint recovery, and overall musculoskeletal function. This research peptide is a fragment of naturally occurring cytomodulins and has been studied for its influence on gene expression in cartilage cells, including chondrocytes. Its application in peptide science centers on its ability to signal the regulation of protein synthesis pathways, modulate inflammation, and support healthy tissue maintenance — making it a molecule of high interest in the field of regenerative peptide research. Real Peptides provides Cartalax in high-purity, vials, independently third-party tested and designed exclusively for research professionals.

What Is the Cartalax Peptide?

Cartalax is a synthetic peptide fragment derived from naturally occurring cytomax proteins found in connective tissue, specifically those involved in cartilage structure and signaling. This short-chain peptide was originally developed and studied in Russian peptide bioregulation programs and has since gained attention in Western research for its ability to regulate gene expression in chondrocytes (cartilage cells). Cartalax is part of a broader class of peptides known as bioregulatory peptides, which are designed to influence protein synthesis and cellular behavior at a targeted tissue level. In the laboratory, Buy Cartalax has been explored for its potential to influence regenerative mechanisms in connective tissue, reduce inflammatory signals within the extracellular matrix, and provide peptide-based signaling that supports the structural integrity of cartilage. These studies often involve models of joint degradation, aging cartilage, and degenerative musculoskeletal conditions. Because Cartalax is a tissue-specific peptide, its action is believed to be more targeted than general regenerative peptides, making it a valuable molecule in peptide-based research on osteoarthritic changes, cartilage regeneration, and immune modulation in musculoskeletal systems. Its small molecular structure allows it to be absorbed and distributed rapidly in tissue models, where it may support reparative processes at the genetic level without triggering broad systemic responses. This makes Cartalax particularly interesting in controlled studies where localized outcomes are preferred.

Why Choose the Cartalax?
Cartalax is a standout in peptide research due to its specificity, characterisation in controlled models, and growing body of data surrounding its effects on joint and cartilage function. Unlike more generalized regenerative peptides such as BPC-157 or TB-500, Cartalax operates with tissue specificity, targeting only those cells involved in cartilage repair and signaling. For researchers exploring:

Age-related cartilage degeneration
Post-injury joint tissue recovery
Experimental models of osteoarthritis
Peptide-based immunomodulation in joints

Cartalax presents a high-value, precision molecule for in-depth experimentation. Its ability to potentially regulate cytokines, repair matrix protein expression, and rebalance cell signaling in connective tissue models provides a framework for applications in both preventative and reparative biological study. In combination with other tissue-support peptides like TB-500, Epithalon, or Thymalin, Cartalax can be a cornerstone compound in comprehensive peptide research stacks. Researchers choose to Buy Cartalax for its:

Narrow tissue specificity (chondrocytes/cartilage)
Established characterisation in preclinical environments
Supportive data from Russian longevity studies
Versatility in stacking with peptides that target muscle, soft tissue, and systemic immune balance

Cartalax Peptide (20mg) for Laboratory Research - Image 2

Click to enlarge

Cartalax Peptide (20mg) for Laboratory Research

$30.00

Cartalax is a short synthetic peptide (Ala-Glu-Asp) belonging to the class of low-molecular-weight peptide bioregulators first described in Russian gerontology and peptide research programs associated with Khavinson. It is referenced in preclinical literature examining connective tissue, epithelial and gene-regulation models, and is handled strictly as a laboratory reference material rather than a therapeutic product.

Real Peptides supplies Cartalax as a 20mg lyophilized powder in a sealed multi-dose vial for in-vitro and other controlled laboratory work. Every batch is submitted to an independent analytical laboratory, and the certificate of analysis for the current lot is published on the lab results pages so identity and purity can be reviewed before purchase.